OpenURL Connection Search

Select item for more details and to access through your institution.

The Kub5-Hera/RPRD1B interactome: a novel role in preserving genetic stability by regulating DNA mismatch repair.
Published in:
Nucleic Acids Research, 2016, v. 44, n. 4, p. 1718, doi. 10.1093/nar/gkv1492
By:
- Patidar, Praveen L.;
- Motea, Edward A.;
- Fattah, Farjana J.;
- Yunyun Zhou;
- Morales, Julio C.;
- Yang Xie;
- Garner, Harold R.;
- Boothman, David A.
Publication type:
Article
Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair.
Published in:
Nucleic Acids Research, 2014, v. 42, n. 8, p. 4996, doi. 10.1093/nar/gku160
By:
- Morales, Julio C.;
- Richard, Patricia;
- Rommel, Amy;
- Fattah, Farjana J.;
- Motea, Edward A.;
- Patidar, Praveen L.;
- Xiao, Ling;
- Leskov, Konstantin;
- Wu, Shwu-Yuan;
- Hittelman, Walter N.;
- Chiang, Cheng-Ming;
- Manley, James L.;
- Boothman, David A.
Publication type:
Article
Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
Published in:
2022
By:
- von Itzstein, Mitchell S.;
- Gonugunta, Amrit S.;
- Wang, Yiqing;
- Sheffield, Thomas;
- Lu, Rong;
- Ali, Sadia;
- Fattah, Farjana J.;
- Xie, Donglu;
- Cai, Jennifer;
- Xie, Yang;
- Gerber, David E.
Publication type:
Correction Notice
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 9, p. 2169, doi. 10.1007/s00262-022-03151-2
By:
- von Itzstein, Mitchell S.;
- Gonugunta, Amrit S.;
- Wang, Yiqing;
- Sheffield, Thomas;
- Lu, Rong;
- Ali, Sadia;
- Fattah, Farjana J.;
- Xie, Donglu;
- Cai, Jennifer;
- Xie, Yang;
- Gerber, David E.
Publication type:
Article
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy.
Published in:
Cancers, 2022, v. 14, n. 5, p. 1327, doi. 10.3390/cancers14051327
By:
- von Itzstein, Mitchell S.;
- Gonugunta, Amrit S.;
- Sheffield, Thomas;
- Homsi, Jade;
- Dowell, Jonathan E.;
- Koh, Andrew Y.;
- Raj, Prithvi;
- Fattah, Farjana;
- Wang, Yiqing;
- Basava, Vijay S.;
- Khan, Shaheen;
- Park, Jason Y.;
- Popat, Vinita;
- Saltarski, Jessica M.;
- Gloria-McCutchen, Yvonne;
- Hsiehchen, David;
- Ostmeyer, Jared;
- Xie, Yang;
- Li, Quan-Zhen;
- Wakeland, Edward K.
Publication type:
Article
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer.
Published in:
2018
By:
- Ke Gong;
- Gao Guo;
- Gerber, David E.;
- Boning Gao;
- Peyton, Michael;
- Chun Huang;
- Minna, John D.;
- Hatanpaa, Kimmo J.;
- Kernstine, Kemp;
- Ling Cai;
- Yang Xie;
- Hong Zhu;
- Fattah, Farjana J.;
- Shanrong Zhang;
- Takahashi, Masaya;
- Mukherjee, Bipasha;
- Burma, Sandeep;
- Dowell, Jonathan;
- Dao, Kathryn;
- Papadimitrakopoulou, Vassiliki A.
Publication type:
journal article
Immune dysregulation in cancer patients developing immune-related adverse events.
Published in:
2019
By:
- Khan, Shaheen;
- Khan, Saad A.;
- Luo, Xin;
- Fattah, Farjana J.;
- Saltarski, Jessica;
- Gloria-McCutchen, Yvonne;
- Lu, Rong;
- Xie, Yang;
- Li, Quan;
- Wakeland, Edward;
- Gerber, David E.
Publication type:
journal article
Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis.
Published in:
2018
By:
- Gerber, David E.;
- Beg, M. Shaalan;
- Fattah, Farjana;
- Frankel, Arthur E.;
- Fatunde, Oluwatomilade;
- Arriaga, Yull;
- Dowell, Jonathan E.;
- Bisen, Ajit;
- Leff, Richard D.;
- Meek, Claudia C.;
- Putnam, William C.;
- Kallem, Raja Reddy;
- Subramaniyan, Indhumathy;
- Dong, Ying;
- Bolluyt, Joyce;
- Sarode, Venetia;
- Luo, Xin;
- Xie, Yang;
- Schwartz, Brian;
- Boothman, David A.
Publication type:
journal article
XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71203-7
By:
- Patidar, Praveen L.;
- Viera, Talysa;
- Morales, Julio C.;
- Singh, Naveen;
- Motea, Edward A.;
- Khandelwal, Megha;
- Fattah, Farjana J.
Publication type:
Article
Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer.
Published in:
2019
By:
- Singh, Jasmine;
- Moore, William;
- Fattah, Farjana;
- Jiang, Xingya;
- Zheng, Jie;
- Kurian, Pamela;
- Beg, Muhammad S.;
- Khan, Saad A.
Publication type:
Case Study
The Transcription Factor TFII-I Promotes DNA Translesion Synthesis and Genomic Stability.
Published in:
PLoS Genetics, 2014, v. 10, n. 6, p. 1, doi. 10.1371/journal.pgen.1004419
By:
- Fattah, Farjana J.;
- Hara, Kodai;
- Fattah, Kazi R.;
- Yang, Chenyi;
- Wu, Nan;
- Warrington, Ross;
- Chen, David J.;
- Zhou, Pengbo;
- Boothman, David A.;
- Yu, Hongtao
Publication type:
Article
Ku Regulates the Non-Homologous End Joining Pathway Choice of DNA Double-Strand Break Repair in Human Somatic Cells.
Published in:
PLoS Genetics, 2010, v. 6, n. 2, p. 1, doi. 10.1371/journal.pgen.1000855
By:
- Fattah, Farjana;
- Eu Han Lee;
- Weisensel, Natalie;
- Yongbao Wang;
- Lichter, Natalie;
- Hendrickson, Eric A.
Publication type:
Article
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer.
Published in:
Journal of Surgical Oncology, 2017, v. 116, n. 1, p. 83, doi. 10.1002/jso.24624
By:
- Beg, Muhammad Shaalan;
- Huang, Xiumei;
- Silvers, Molly A.;
- Gerber, David E.;
- Bolluyt, Joyce;
- Sarode, Venetia;
- Fattah, Farjana;
- Deberardinis, Ralph J.;
- Merritt, Matthew E.;
- Xie, Xian-Jin;
- Leff, Richard;
- Laheru, Daniel;
- Boothman, David A.
Publication type:
Article
Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A "Two‐Hit" Autoimmune Toxicity or Clinical Predisposition?
Published in:
Oncologist, 2020, v. 25, n. 8, p. e1242, doi. 10.1634/theoncologist.2019-0911
By:
- von Itzstein, Mitchell S.;
- Khan, Shaheen;
- Popat, Vinita;
- Lu, Rong;
- Khan, Saad A.;
- Fattah, Farjana J.;
- Park, Jason Y.;
- Bermas, Bonnie L.;
- Karp, David R.;
- Ahmed, Murtaza;
- Saltarski, Jessica M.;
- Gloria‐McCutchen, Yvonne;
- Xie, Yang;
- Li, Quan‐Zhen;
- Wakeland, Edward K.;
- Gerber, David E.
Publication type:
Article
Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon.
Published in:
Oncologist, 2020, v. 25, n. 5, p. e753, doi. 10.1634/theoncologist.2019-0666
By:
- Khan, Shaheen;
- von Itzstein, Mitchell S.;
- Lu, Rong;
- Bermas, Bonnie L.;
- Karp, David R.;
- Khan, Saad A.;
- Fattah, Farjana J.;
- Park, Jason Y.;
- Saltarski, Jessica M.;
- Gloria‐McCutchen, Yvonne;
- Xie, Yang;
- Li, Quan‐Zhen;
- Wakeland, Edward K.;
- Gerber, David E.
Publication type:
Article
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1351739
By:
- von Itzstein, Mitchell S.;
- Yuqiu Yang;
- Yiqing Wang;
- Hsiehchen, David;
- Sheffield, Thomas Y.;
- Fattah, Farjana;
- Popat, Vinita;
- Ahmed, Murtaza;
- Homsi, Jade;
- Dowell, Jonathan E.;
- Rashdan, Sawsan;
- Lohrey, Jay;
- Hammers, Hans J.;
- Hughes, Randall S.;
- Tao Wang;
- Yang Xie;
- Gerber, David E.
Publication type:
Article
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study.
Published in:
Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 1, p. 154, doi. 10.1515/cclm-2022-0471
By:
- Ulndreaj, Antigona;
- Brinc, Davor;
- Altan, Mehmet;
- Pons-Belda, Oscar D.;
- Fernandez-Uriarte, Amaia;
- Mu-Mosley, Hong;
- Fattah, Farjana;
- von Itzstein, Mitchell S.;
- Soosaipillai, Antoninus;
- Kulasingam, Vathany;
- Palaskas, Nicolas L.;
- Gerber, David E.;
- Diamandis, Eleftherios P.;
- Heymach, John V.;
- Prassas, Ioannis
Publication type:
Article

Found: 17